HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prolymphocytic Leukemia

A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.
Also Known As:
Leukemia, Prolymphocytic; Leukemias, Prolymphocytic; Prolymphocytic Leukemias
Networked: 173 relevant articles (16 outcomes, 10 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
2. Non-Hodgkin Lymphoma (Lymphosarcoma)
3. Leukemia
4. Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
5. Neoplasms (Cancer)

Experts

1. Keating, Michael J: 5 articles (01/2003 - 02/2002)
2. O'Brien, Susan: 4 articles (02/2005 - 02/2002)
3. Dreger, P: 3 articles (01/2019 - 05/2012)
4. Larson, Richard A: 3 articles (05/2015 - 09/2002)
5. Rai, Kanti R: 3 articles (02/2013 - 09/2002)
6. Nagler, A: 2 articles (01/2019 - 05/2012)
7. Schetelig, J: 2 articles (01/2019 - 05/2012)
8. Sellner, L: 2 articles (01/2019 - 04/2017)
9. Volin, L: 2 articles (01/2019 - 05/2012)
10. Wiktor-Jedrzejczak, W: 2 articles (01/2019 - 05/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Prolymphocytic Leukemia:
1. fludarabineIBA
2. Alemtuzumab (Campath)FDA Link
3. Monoclonal AntibodiesIBA
4. Rituximab (Mabthera)FDA Link
5. AntigensIBA
6. Cyclophosphamide (Cytoxan)FDA LinkGeneric
7. Pentostatin (Nipent)FDA LinkGeneric
8. Cytarabine (Cytosar-U)FDA LinkGeneric
9. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10. Cisplatin (Platino)FDA LinkGeneric

Therapies and Procedures

1. Stem Cell Transplantation
2. Radiotherapy
3. Therapeutics
4. Immunotherapy
5. Transplantation